Kai-Hsi Lu

516 total citations
18 papers, 391 citations indexed

About

Kai-Hsi Lu is a scholar working on Molecular Biology, Cancer Research and Reproductive Medicine. According to data from OpenAlex, Kai-Hsi Lu has authored 18 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Molecular Biology, 9 papers in Cancer Research and 4 papers in Reproductive Medicine. Recurrent topics in Kai-Hsi Lu's work include Ovarian cancer diagnosis and treatment (4 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (3 papers). Kai-Hsi Lu is often cited by papers focused on Ovarian cancer diagnosis and treatment (4 papers), MicroRNA in disease regulation (4 papers) and Ferroptosis and cancer prognosis (3 papers). Kai-Hsi Lu collaborates with scholars based in Taiwan, United States and China. Kai-Hsi Lu's co-authors include Yi‐Ping Yang, Ming-Teh Chen, Mong‐Lien Wang, Chi-Shuan Huang, Yueh Chien, Yi‐Wei Chen, Pin‐I Huang, Shou‐Dong Lee, Ping‐Hsing Tsai and Hsin‐I Ma and has published in prestigious journals such as Journal of Clinical Oncology, Molecular Cell and Cancer Research.

In The Last Decade

Kai-Hsi Lu

18 papers receiving 385 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai-Hsi Lu Taiwan 10 255 172 102 54 48 18 391
Suchitra Natarajan United States 8 226 0.9× 126 0.7× 130 1.3× 48 0.9× 18 0.4× 13 379
Pradeep Chaluvally–Raghavan United States 12 344 1.3× 236 1.4× 133 1.3× 117 2.2× 22 0.5× 24 520
Svetlana Miklikova Slovakia 12 202 0.8× 117 0.7× 168 1.6× 48 0.9× 24 0.5× 17 401
Boxuan Liu China 12 243 1.0× 134 0.8× 61 0.6× 64 1.2× 57 1.2× 25 374
Mónica Fernández‐Cortés Spain 8 283 1.1× 152 0.9× 153 1.5× 45 0.8× 20 0.4× 9 408
Katarzyna Wójcik‐Krowiranda Poland 9 299 1.2× 184 1.1× 79 0.8× 51 0.9× 10 0.2× 28 435
Janani Kumar Australia 9 215 0.8× 109 0.6× 204 2.0× 70 1.3× 22 0.5× 10 433
Reilly L. Kidwell United States 8 413 1.6× 191 1.1× 114 1.1× 52 1.0× 63 1.3× 14 517
Zewei Tu China 11 259 1.0× 175 1.0× 82 0.8× 50 0.9× 37 0.8× 33 377

Countries citing papers authored by Kai-Hsi Lu

Since Specialization
Citations

This map shows the geographic impact of Kai-Hsi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai-Hsi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai-Hsi Lu more than expected).

Fields of papers citing papers by Kai-Hsi Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai-Hsi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai-Hsi Lu. The network helps show where Kai-Hsi Lu may publish in the future.

Co-authorship network of co-authors of Kai-Hsi Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Kai-Hsi Lu. A scholar is included among the top collaborators of Kai-Hsi Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai-Hsi Lu. Kai-Hsi Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Lu, Kai-Hsi, et al.. (2025). Are There Any Renoprotective Effects of SGLT2 Inhibitors in Heart Transplant Recipients with Diabetes?. PubMed. 41(2). 242–250. 1 indexed citations
2.
Liu, Chun‐Yu, Y. M. Dennis Lo, Shih‐Hwa Chiou, et al.. (2023). Cytotoxic T-lymphocyte antigen 4 polymorphisms and breast cancer susceptibility: Evidence from a meta-analysis. Journal of the Chinese Medical Association. 86(2). 207–219. 9 indexed citations
3.
Wu, Peï-Yu, et al.. (2022). β-Lapachone, an NQO1 activator, alleviates diabetic cardiomyopathy by regulating antioxidant ability and mitochondrial function. Phytomedicine. 104. 154255–154255. 9 indexed citations
4.
Gao, Hong‐Wei, Chia-Ming Chang, Kai-Hsi Lu, et al.. (2021). Synergistic AHR Binding Pathway with EMT Effects on Serous Ovarian Tumors Recognized by Multidisciplinary Integrated Analysis. Biomedicines. 9(8). 866–866. 3 indexed citations
5.
Chang, Chia-Ming, Yao‐Feng Li, Hsin‐Chung Lin, et al.. (2021). Dysregulated Immunological Functionome and Dysfunctional Metabolic Pathway Recognized for the Pathogenesis of Borderline Ovarian Tumors by Integrative Polygenic Analytics. International Journal of Molecular Sciences. 22(8). 4105–4105. 1 indexed citations
6.
Yarmishyn, Aliaksandr A., Yi‐Ping Yang, Kai-Hsi Lu, et al.. (2020). Musashi-1 promotes cancer stem cell properties of glioblastoma cells via upregulation of YTHDF1. Cancer Cell International. 20(1). 597–597. 55 indexed citations
7.
Wang, Chien‐Ying, Heng‐Fu Lin, Chun‐Yu Liu, et al.. (2020). Using multiple-steps bioinformatic analysis to predict the potential microRNA targets by cardiogenic HoxA11. Journal of the Chinese Medical Association. 84(1). 68–72. 1 indexed citations
8.
Wang, Chien‐Ying, Chi-Shuan Huang, Yi‐Ping Yang, et al.. (2019). The subpopulation of CD44-positive cells promoted tumorigenicity and metastatic ability in lung adenocarcinoma. Journal of the Chinese Medical Association. 82(3). 196–201. 24 indexed citations
9.
Chien, Yueh, Ping‐Hsing Tsai, Kai-Hsi Lu, et al.. (2019). CircularRNA as novel biomarkers in liver diseases. Journal of the Chinese Medical Association. 83(1). 15–17. 35 indexed citations
10.
Peng, Chi‐Hsien, Lin‐Chung Woung, Kai-Hsi Lu, et al.. (2018). Acoustic waves improves retroviral transduction in human retinal stem cells. Journal of the Chinese Medical Association. 81(9). 830–836. 3 indexed citations
11.
Huang, Chi-Shuan, et al.. (2018). Generation of high quality of hepatocyte-like cells from induced pluripotent stem cells with Parp1 but lacking c-Myc. Journal of the Chinese Medical Association. 81(10). 871–877. 7 indexed citations
12.
Chang, Cheng‐Chang, Kai-Hsi Lu, Peng‐Hui Wang, et al.. (2018). Key Immunological Functions Involved in the Progression of Epithelial Ovarian Serous Carcinoma Discovered by the Gene Ontology-Based Immunofunctionome Analysis. International Journal of Molecular Sciences. 19(11). 3311–3311. 13 indexed citations
13.
Ouyang, Wen‐Chen, Yi‐Wen Liao, Pei‐Ni Chen, et al.. (2017). Hinokitiol suppresses cancer stemness and oncogenicity in glioma stem cells by Nrf2 regulation. Cancer Chemotherapy and Pharmacology. 80(2). 411–419. 30 indexed citations
14.
Chang, Chia-Ming, Mong‐Lien Wang, Kai-Hsi Lu, et al.. (2017). Integrating the dysregulated inflammasome-based molecular functionome in the malignant transformation of endometriosis-associated ovarian carcinoma. Oncotarget. 9(3). 3704–3726. 29 indexed citations
15.
Yang, Yi‐Ping, Chi-Shuan Huang, Kai-Hsi Lu, et al.. (2016). Sox2, a stemness gene, regulates tumor-initiating and drug-resistant properties in CD133-positive glioblastoma stem cells. Journal of the Chinese Medical Association. 79(10). 538–545. 79 indexed citations
16.
Chiou, Shih-Hwa, Guang‐Yuh Chiou, & Kai-Hsi Lu. (2013). Abstract 228: Curcumin attenuates tumor initiating stem-like property of head and neck cancer through miR145 axis-mediated paracrine signaling.. Cancer Research. 73(8_Supplement). 228–228. 1 indexed citations
17.
Chiou, Guang‐Yuh, Chian‐Shiu Chien, Mong‐Lien Wang, et al.. (2013). Epigenetic Regulation of the miR142-3p/Interleukin-6 Circuit in Glioblastoma. Molecular Cell. 52(5). 693–706. 81 indexed citations
18.
Hennessy, Bryan T., Kirsten M. Timms, Mark Carey, et al.. (2009). Somatic BRCA status in ovarian tumors. Journal of Clinical Oncology. 27(15_suppl). 5528–5528. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Suchitra Natarajan Breakdown of academic impact, for papers by Pradeep Chaluvally–Raghavan Breakdown of academic impact, for papers by Svetlana Miklikova Breakdown of academic impact, for papers by Boxuan Liu Breakdown of academic impact, for papers by Mónica Fernández‐Cortés Breakdown of academic impact, for papers by Katarzyna Wójcik‐Krowiranda Breakdown of academic impact, for papers by Janani Kumar Breakdown of academic impact, for papers by Reilly L. Kidwell Breakdown of academic impact, for papers by Zewei Tu
Rankless by CCL
2026